Cookies show us what works. Privacy
Cookies show us what works. Privacy
31 funds hold it · Insiders net selling
Net selling: insiders sold $124.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 2, 2026
Period ending
Sep 30, 2026
Earnings per share
$0.60 expected
Estimates as of Nov 9, 2026
EPS expected
$0.65 to $0.78
Revenue expected
13 analysts
Last 30 days
Analysts cutting estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 2, 2026 | $0.71est. $0.60 | +19.04%beat | $235.0MSEC filing | +52.4%from $154.2M |
| Jun 30, 2026Reported Aug 4, 2026 | $0.59est. $0.61 | -4.07%miss | $212.8MSEC filing | +53.0%from $139.1M |
| Mar 31, 2026Reported May 5, 2026 | $0.45est. $0.40 | +13.29%beat | $182.3MSEC filing | +47.2%from $123.8M |
| Dec 31, 2025Reported Feb 10, 2026 | $0.49est. $0.43 | +15.15%beat | $170.7MAlpha Vantage | No year-ago quarter |
| Sep 30, 2025Reported Nov 4, 2025 | $0.44est. $0.24 | +83.33%beat | $154.2MSEC filing | +53.3%from $100.6M |
| Jun 30, 2025Reported Aug 5, 2025 | $0.70est. $0.09 | +$0.61beat | $139.1MSEC filing | +54.9%from $89.8M |
| Mar 31, 2025Reported May 5, 2025 | $0.20Reported | No estimate | $123.8MSEC filing | No year-ago quarter |
| Sep 30, 2024Reported Nov 7, 2025 | Not on file | No estimate | $100.6MSEC filing | No year-ago quarter |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $170.7M | $182.3M | $212.8M | $235.0M |
| Cost of what it sold | $26.6M | $28.1M | $28.9M | $30.6M |
| Gross profit | $144.2M | $154.2M | $183.9M | $204.3M |
| What it spent | ||||
| Research and development | $32.8M | $30.3M | $34.1M | $37.5M |
| Sales and admin | $24.4M | $23.0M | $28.0M | $31.3M |
| Other operating costs | $59.8M | $68.8M | $81.4M | $85.2M |
| Total operating expenses | $116.9M | $122.2M | $143.5M | $154.0M |
| What was left | ||||
| Operating profit | $27.3M | $32.1M | $40.4M | $50.3M |
| Profit before tax | $32.2M | $35.9M | $44.4M | $53.7M |
| Tax | $122.0K | $814.0K | $740.0K | -$3.7M |
| Net profit | $32.1M | $35.1M | $43.7M | $57.4M |
| EBITDA | $29.7M | $33.2M | $45.5M | $55.9M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bearish
Bessemer funds sell Hinge Health (HNGE) shares at prices up to $125.90 on November 11.
Leans bearishNov 13Hinge Health CFO James Budge sells $4.37M in stock, prices $119.52-$123.34 By Investing.com
NeutralNov 13Five sales follow a share conversion by Hinge Health (HNGE) co-founder Gabriel M.I. Mecklenburg.
Leans bearishNov 13After relinquishing shares for taxes, Hinge Health (HNGE) CFO holds 292,114 shares.
NeutralNov 3After relinquishing shares for taxes, Hinge Health (HNGE) president holds 665,247 shares.
NeutralNov 336 macro signals shaping HNGE right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results